Ultracentrifugal Analysis.--Purified human C3 treated with heart tissue was analyzed by ultracentrifugation in a sucrose density gradient. Centrifugation was performed at 55,000 rpm for 15 hr (4°C) in sucrose (5-350/0) dissolved in phosphate buffer (pH 7.3, ionic strength 0.05). Details of this procedure are described elsewhere (2, 6) .
Gd Filtration.--The same tissue-treated C3 preparation used for density gradient analysis was also eluted from Sephadex G-75 (Pharmacia, Piscataway, N.J.) with phosphate buffer (pH 7.3, ionic strength 0.05), and the fractions were scanned for chemotactic activity. Protein or peptide markers in the density gradients included bovine serum albumin, cytochrome c (both from Mann Research Laboratories, New York, N. Y.), and glucagon (Eli Lilly and Co., Indianapolis, Ind.).
Enzyme Stndies.--CrystaiYlzed trypsin and chromatographically purified soybean trypsin inhibitor were products of Mann Research Laboratories. Each was dissolved in phosphatebuffered saline (pH 7.3) immediately" before use. Organophosphonate compounds of the type previously used in chemotaxis experiments (7) and employed under a variety of experimental conditions in which inhibition of serine esterases is desired (8) were kindly supplied by Dr. Elmer L. Becker (Walter Reed Army Institute of Research). The homologous phosphonate series used included the ¢0-chloroalkyl p-nitrophenyl ethyl phosphonates containing alkyl chains of 3, 4, 5, or 6 carbon atoms with the chloro group in the terminal carbon atom. It is well known that these compounds inhibit many types of esterases, including trypsin, chymotrypsin, and choline esterases, each of which has a serine atom at or near the active site of the enzyme (8) . Heart tissue was pretreated with the appropriate phosphonate dissolved in phosphate-buffered saline (pH 7.3) in a volume of 0.5 ml. After incubation at room temperature for 20 min, tissues were diluted to 8 ml with buffered saline and washed twice before incubation with rat serum.
Competitive substrate inhibition was studied using heart tissue, which contains a protease capable of hydrolyzing rat or human C3. In order to determine whether a defined ester could competitively inhibit this reaction, various synthetic amino acid esters were added with the substrate (consisting of purified human C3 or C3 in rat serum), mixed with heart tissue, and incubated at 37°C for 90 min. To provide adequate controls in this experiment, esters were added either at the beginning or at the end of the incubation period. The tissue was then re-moved by centrlfugation, and the superuatant was tested for chemotacfic activity. The following synthetic esters, obtained from Mann Research Laboratories, New York, N. Y., were used: p-tosyl-L-arginine methyl ester HCI (TAMe), M.A. (Mann assayed); benzoylarginine methyl ester hydrochloride (BAMe), M.A.; N-acetyltyrosine ethyl ester, M.A.; glycylglycine ethyl ester; and glycine ethyl ester.
RESULTS

Ability of Various Tissues to Generate Chemotactic Activity in Serum.--Six
different tissues from rats were tested for their ability to generate chemotactic activity in fresh autologous rat serum. In the experiments to be described, any activity found in untreated rat serum or in supernatants of tissue incubated in In general, such control values were less than 20 % of activity found in serum incubated with tissue. In two different experiments it became evident that most tissues were capable of generating chemotactic activity in rat serum (Table I) . There was some variability between liver and kidney from one experiment to the next, but in several subsequent experiments both tissues generated chemotactic activity in rat serum, kidney tending to be more active. Heart tissue has consistently been the most effective tissue for generation of chemotactic activity in serum, whereas skeletal muscle has shown little or no ability. As a general rule, it can be stated that most tissues of the rat are able to generate chemotactic activity in homologous serum.
Chemotactic Activity as a Function of Dose of Heart
Tissue and Rat Serum.--In order to define the features of this chemotactic factor-generating system, the amount of serum was varied, maintaining a constant reaction volume of 0.3 ml (phosphate-buffered saline used as necessary) with 25 mg heart tissue. Fig. 1 shows that the amount of chemotactic activity appearing in the supernatant was related to the amount of sermn used. Maximal activity was achieved at 0.2 ml, with a drop-off in chemotactic activity when 0.3 ml serum was used. Fig. 2 indicates that with a constant amount of serum, the chemotactic activity appearing was a function of the amount of heart tissue used, 40 rag/0.1 ml serum giving maximal activity, whereas the largest dose of heart tissue (50 rag/0.1 ml serum) resulted in considerably less chemotactic activity. The reason for this reduction in activity is not known.
Chemotactic Activity as a Function of Duration of Incubation.--The amount of chemotactic activity generated by the interaction of heart tissue with serum was directly related to the duration of incubation of heart tissue with rat serum at 37°C (Fig. 3, experiments A and B) . Maximal activity appeared in the supernatant after an incubation period of 60-90 min. Shorter periods of incubation resulted in less activity, and prolongation of the period beyond 90 min did not result in additional chemotactic activity. Also shown in this figure is the ability of heart tissue to react with human C3 to give chemotactic activity. In this case, a fairly abrupt reduction in activity occurred if the period of incubation was extended beyond 90 min. The ability of C3 to substitute for serum is discussed in following sections.
Requirements of Serum in Generation of Chemotactic Activity.--In order to find
out more about the way in which heart tissue interacted with rat serum to result in chemotactic activity, several manipulations were performed. The controls, consisting of supernatants from heart tissue incubated in saline or serum, and serum by itself, as well as heart-serum-EDTA, are listed in Table  II . Heating of rat serum before or after incubation with heart tissue precluded the appearance of, or resulted in the disappearance of, chemotactic activity. Compelling evidence that the chemotactic factor was related to C3 was provided 400 by the finding that anti-C3 (~lc-globulin) abolished chemotactic activity regardless of whether the antibody was added at the beginning or the end of the incubation period. However, the fact that EDTA in serum caused a 3-fold enhancement in chemotactic activity indicated that conventional triggering of the complement system (requiring the first and the second components of complement) was not occurring. The mechanism of enhancement of chemotactic activity by EDTA has not been determined. It also became apparent that the presence of trypsin inhibitor in the system precluded generation of the chemotactic factor (Table II) , suggesting the role of a proteolytic enzyme.
Additional evidence that C3 was involved in generation of chemotactic activity is presented in Table III . Here the enhancing effect of EDTA in development of chemotactic activity is again seen. Rat serum treated with 
Chemotactic activity
Heart + saline Heart + rat serum Rat serum Rat serum + EDTA (0.02 M) Heart + heated rat serum (56°C, 30 rain) Heart + rat serum, then heated Heart + rat serum + 50 #1 anti-rat C3 added:
Before incubation After incubation Heart + rat serum + EDTA (0.02 M) Heart + rat serum + trypsin inhibitor (50 #g) Heart + 50 #g C3 + trypsin inhibitor (50 #g) 0 Heart + 50 #g C3 + 0.02 ~ EDTA + trypsin inhibitor:
At beginning 17 At end 400 Heart + 50 #g C5 0 KSCN in order to inactivate C3 and C5 failed to support generation of activity (experiment A). However, the addition of 100 gg human C3 corrected this deficiency. That C3 alone, but not C5, was able to support generation of chemotactic activity is shown by experiment B, Table III . The addition of trypsin inhibitor to the tissue-C3 mixture blocked the appearance of chemo-tactic activity, as was the case when serum instead of C3 was used (Table II) . And, just as EDTA enhanced the amount of chemotactic activity in serum produced by heart tissue, it also enhanced the ability of heart tissue to generate chemotactic activity in purified C3. Using the heart-C3-EDTA system, trypsin inhibitor was effective only if added at the beginning of the incubation period. Little effect was found if the inhibitor was added at the end of the incubation time (Table III) . In line with the effect of anti-C3 on chemotactic activity, the specificity for C3 in the reaction became apparent when it was found that incubation of human C5 (#~-globulin) with heart tissue was unproductive of chemotactic activity (Table III, (Fig. 1) , the amount of human C3 (/31e-globulin) added to heart tissue determined the amount of chemotactic activity appearing. In two different experiments, parallel dose-response curves were obtained (Fig.  4, experiments A and B) . In experiments not reported here, kidney, spleen, lung, and liver also had the ability to generate chemotactic activity when incubated with human C3, indicating that this is a common feature of the tissue studied. We have also had the opportunity to study fresh human tissues from the various organs and have found them also to be active in generating chemotactic activity either in autologous serum or in purified C3.
Identification of Chemotactic Factor as a Split
Product of C3.--The foregoing studies strongly suggested that the chemotactic factor generated by interaction of heart tissue with serum was a product of C3, possibly a cleavage product produced by the action of a proteolytic enzyme in heart tissue. In order to assess this possibility, C3 was incubated with heart tissue (in the same manner described in Fig. 4) , and the supernatant was subjected to analysis by gel filtration and ultracentrifugation. Sucrose density gradient analysis of the treated C3 revealed a heterogeneity of chemotactic factors produced by incubation with heart (Fig. 5, middle frame) or heaxt-EDTA (Fig. 5, bottom frame) , with chemotactic activity appearing in the general position determined by a cytochrome c marker (Fig. 5, top frame) and a zone of more rapidly sedimenting Fro. 5. Sucrose density gradient analysis of human C3 treated with heart tissue, showing positions of chemotactic activity (vertical bars), C3, and protein standards. C3 was quantitated by immunoditfusion in agar gel. activity which varied according to the preparation. It also became apparent that the appearance of chemotactic activity could be related to reduction in the velocity of sedimentation of C3. Calculations revealed a drop in the known sedimentation rate of 9.5 for C3 to values between 8.5 (bottom frame of Fig. 5 ) and 7.4 (middle frame of Fig. 5 ). This reduction seems to depend upon particular conditions of the experiment and is in line with the concept that the chemotactic factor is a fragment split from the native C3 molecule.
More rigorous study of the C3 cleavage products with chemotactic activity was carried out by filtration of the treated C3 in Sephadex G-75 (Fig. 6) . Heterogeneity of chemotactic activity was confirmed with the finding of zones of chemotactic activitv coinciding with the cytochrome marker as well as activity in a position between the bovine serum albumin and cytochrome c markers. Using the Andrews ulot to estimate molecular weight (9), the approximate weights of these C3 fragments were 30,000 and 14,000. In repeated experiments of this kind, chemot~tic activity has been found consistently in the vicinity of the cytochrome marker, whereas the other zone, representing a less retarded factor in gel filtration, has varied between the void volume and the Fig. 6 . Behavior of chemotactic factors in gel filtration. Human C3 was pretreated with rat heart tissue, then eluted from Sephadex G-75. Two major zones of chemotactic activity are present. BSA is bovine serum albumin. cytochrome position. Chemotactic activity has thus far not been found in a more retarded position (i.e. beyond the cytochrome marker).
Characterization of a Protease in Heart
Tissue.--It appeared likely that a trypsin-like enzyme in heart tissue was involved in the generation of chemotactic factors from C3. In order to determine this possibility, heart tissue was pretreated with saline or with trypsin inhibitor or the chloroalkyl phosphonate series (inactivators of serine esterases), since both types of compounds would be expected to inhibit a trypsin-like enzyme. Mter a 20 min preincubation at room temperature, heart tissues were washed twice and then added to rat serum and incubated for 90 rain. As is evident in Table IV , pretreatment with trypsin inhibitor completely blocked the ability of heart tissue to interact with serum and generate a chemotactic factor. In varying degrees, from 55 to 100%, the various chloroalkyl phosphonates also inhibited the capacity of heart tissue to generate chemotactic activity in rat serum.
Ability of Esters to
Interfere with Action of Tissue Protease on C3.--It appeared possible to obtain information on the nature of the heart enzyme by the addition of amino acid esters that would compete with the C3 substrate. Experiments listed in Table V were devised to test this possibility. Both rat serum and purified human C3 were used as the source of substrate, and esters were added 25 mg heart tissue pretreated with 0.4 ml 8 X 10 -4 M phosphonate as above, then washed twice and incubated with rat serum. The same protocol was followed with the trypsin inhibitor.
at either the start or the end of the period of incubation. Conditions included 20 mg heart tissue, 0.1 ml ester solution (0.07 M), and 0.1 ml rat serum or C3 (100 #g). After incubation, the tissue was removed by centrifugation and the supernatant was tested for chemotactic activity. When necessary, the pH of the supernatant was adjusted to neutrality before testing for chemotactic activity. It was found that esters appropriate to the functional features of an enzyme like trypsin (TAMe and BAMe) were effective inhibitors in the generation of chemotactic activity, whereas the aromatic amino acid ester N-acetyltyrosine ethyl ester and other esters (glycine ethyl ester and glycylglycine ethyl ester) had little or no effect. The important control in this experiment, to rule out nonspecific "toxic" effects of esters on cells, was the addition of ester at the end of the period of incubation. With a single exception, only TAMe and BAMe inhibited the generation of chemotactic activity if added at the beginning of the period of incubation of tissue with substrate. N-Acetyltyrosine ethyl ester had inhibitory effects (36-43 % when serum was used as the substrate) that were nonspedfic; that is, the inhibition was unrelated to the period of incubation of tissue with substrate. When purified C3 was used as the substrate, the ester was ineffective regardless of the time of addition (Table V) . These results are compatible with the notion that the protease in heart tissue is a trypsin-like enzyme. 
DISCUSSION
These results seem to establish clearly that many tissues cangenerate chemotactic activity in serum and that, at least in the case of heart tissue, this involves an interaction between C3 and a tissue-contained, trypsin-like enzyme. The interaction of the protease and C3 results in the production of C3 fragmentation products with chemotactic activity. The relatively large amount of tissue (milligram quantities) required to cleave C3 probably simply reflects the very inefficient contact of enzyme with substrate. In most respects, these findings confirm and extend those of Hurley (1), who described an interaction between rat tissue and serum that resulted in chemotactic activity in vitro for neutrophils. It seems quite possible that these data provide a plausible explanation for the development of the acute inflammatory response in mechanically injured tissue; namely, through the release of the tissue protease, C3 in the vicinity of the injured tissue can serve as a substrate for the production of phlogistic (leukotactic) factors. Thus, in the case of burned tissue, mechanically disrupted tissue, or infarcted tissue, to name a few examples, the stage would be set for the induction of the acute inflammatory response by the generation of C3 chemotactic factors. This would provide an alternative explanation for the classical view that the appearance of neutrophilic leukocytes simply reflects their adherence ("sticking") to altered endothelium and subsequent random migration of these cells into extravascular sites. However, in order to test the relevance of the hypothesis presented in this paper, it will be necessary to show the release of the protease from damaged tissue and the appearance of C3 fragments with chemotactic activity in the same tissue. Preliminary supporting evidence for this latter point has already been obtained.
Once again, in considering the acute inflammatory response, we come to the complement system as a mediator. It has previously been shown that immunological triggering of the complement system will result in production of factors with chemotactic (2, 6, 10) as well as vasoactive properties (11) (12) (13) . Increasingly apparent is the fact that the complement system contains a series of substrates from which several phlogistic mediators can be generated in such a manner that only one complement component is needed, the rest of the eight components being bypassed. This is true for the production of C3 or C5 anaphylatoxin by trypsin (11) (12) (13) or cobra venom factor (14) , as well as for the generation of chemotactic factors from C3 (15) or C5 (16, 17) . Table VI indicates the multiplicity of chemotactic factors capable of being generated from the complement system. These factors can be produc__ed either by sequential interaction of the complement system, resulting in C567 or a C5 fragmentation product, or by direct interaction of a single complement component with an enzyme not intrinsic to the complement system, such as plasmin or trypsin. Quite apparent in Table VI is the multiplicity of agents capable of directly interacting with C3 or C5 to give a chemotactic product. As more data of this type accumulate, one begins to wonder if the complement system is more important as a mediator for nonimmunologically triggered events leading to production of phlogistic factors, rather than in its historical (immunological) role. If experimental evidence can be obtained to suggest a relation between C3 products and the inflammatory response to "nonspecific" tissue injury, this would have therapeutic implications. In cases of inflammation in or around vital areas, such as the central nervous system, the facial, or respiratory areas, where the inflammatory response poses a threat to vital organ function, it would be very desirable to know more about the mechanism of inflammation. The data presented in this report suggest one approach to the question.
The precise identification of the trypsin-like enzyme in heart tissue awaits further work. It seemed possible that activated plasminogen might be the critical enzyme. However, two observations militate against this possibility. Kwaan and Astrup failed to find plasmin activity in rat heart tissue (18) . Furthermore, the split product of C3, at least as far as human plasmin is concerned, is of a lower molecular weight, around 6000 (15) . However, neither observation rigorously precludes the possible role of plasmin. That thrombin might be involved in the reaction is under consideration, but no evidence so far completely substantiates or denies this possibility. Certainly the trypsin-like enzyme has properties different from the trypsin (beef) product used in prior experiments (17) , in which this enzyme generated little chemotactic activity from C3. But that the protease closely resembles trypsin from a functional point of view is unquestioned. Whether or not the protease active on C3 is identical with any more well-defined proteases in tissue is not known at this time.
SUMMARY
When various rat tissues are incubated in homologous serum, a factor chemotactic in vitro for neutrophils is generated. The amount of chcmotactic activity is a function of duration of incubation and the quantity of heart tissue or serum employed. Addition of trypsin inhibitor or antibody to the third component of complement (C3) precludes generation of chemotactic activity. In addition, antibody to C3 ablates chemotactic activity even after its formation.
Purified human C3 (/3zc-globulin) effectively substitutes for serum in the generation of chemotactic activity by heart tissue. The active product, as determined by gel filtration or by ultracentrifugal analysis in a sucrose density gradient, appears to be a cleavage product of C3 with a molecular weight of approximately 14,000. In addition, a larger C3 fragmentation product varying in molecular weight, depending upon experimental conditions, is also found.
The protease in rat heart tissue capable of cleaving C3 into chcmotactic fragments is a serine esterase with trypsin-like properties and can bc inhibited by organophophorous compounds or trypsin inhibitors. The use of amino acid esters in the manner of competitive substrate inhibition confirms the trypsinlike nature of the protease.
The presence of a proteasc in heart, and presumably in other normal tissues, capable of fragmenting C3 into factors with chemotactic activities may explain the development of the acute inflammatory response when tissues are nonspecifically injured. If true, this would reinforce the role of the complement system in the mediation of nonimmunologically induced inflammation. Table VI. 
